secwatch.observer — SEC 8-K summary
======================================

Issuer:     Curaleaf Holdings, Inc. (CURLF)
CIK:        0001756770
Form:       8-K
Filed at:   2026-11-05T17:50:55+00:00
Accession:  0001628280-26-070782
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Curaleaf says enhanced Aurora bid stands; faults Aurora board for Organigram diligence access
--------------------------------------------------------------------------------

- Curaleaf's enhanced premium offer, dated October 6, 2026, to buy all outstanding Aurora common shares remains outstanding; original circular dated August 18, 2026.
- Curaleaf says Aurora's board granted Organigram due diligence access but refused to engage Curaleaf, which it calls a 'gross dereliction' of fiduciary duties.
- Curaleaf says it is awaiting undisclosed terms of Organigram's alternative deal: any break fee, management and board composition, and investor rights granted to BAT.
- Curaleaf notes neither Aurora nor Organigram said whether their transaction is dilutive or accretive to shareholders.
- Curaleaf argues its bid offers better value, a stronger capital markets profile, greater certainty and speed to close, and greater synergies than a 'smaller, less liquid' Organigram.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756770/000162828026070782/0001628280-26-070782-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756770/000162828026070782/curlf-20261103.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-070782

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer